Browsing Tag
Sandoz Group AG
3 posts
Avecho Biotechnology (ASX: AVE) secures Japanese patent for CBD capsule as global licensing strategy expands
Avecho Biotechnology’s Japanese patent adds another major jurisdiction to the intellectual property estate surrounding its TPM-enhanced cannabidiol capsule. The grant strengthens the company’s negotiating position, but clinical completion, regulatory approval and regional licensing remain the decisive commercial tests.
Avecho Biotechnology clears Phase III insomnia interim review as ASX:AVE surges 40%
Avecho Biotechnology’s CBD insomnia trial will continue with its original 519-patient design after an independent monitoring board found that predefined efficacy and safety requirements had been satisfied.
Avecho Biotechnology secures $19m+ deal with Sandoz for CBD insomnia treatment in Australia
Avecho Biotechnology Limited has entered an exclusive 10-year development and licensing agreement with Sandoz Group AG to commercialise…